asthma in adolescents and adults. The beneficial role of corticosteroid administration in reducing the need for hospitalisation in asthma episodes in adults has been demonstrated, however the evidence supporting corticosteroid use in preschool aged children with acute wheeze exacerbations is less robust. Aim To assess the efficacy of oral prednisolone in pre-schoolaged children presenting to a paediatric emergency department (PED) with viral associated wheeze. Methods A superiority analysis of the randomised, doubleblind placebo controlled trial, comparing the effect of a 3 day course of daily oral prednisolone (1 mg/kg/day) with placebo on the primary outcome of length of hospital stay in children (aged 24 to 72 months) presenting to a tertiary PED with VAW. (124, 971)); the unadjusted ratio of geometric means for LOS was 0·79 (95% CI; 0·64, 0·97; p=0·0227, n=605). The prednisolone group had significantly reduced risk, relative to placebo group, of the LOS exceeding either 7 or 12 hours, adjusted RR 0·82 (95% CI; 0·.69,0·96; p=0·0166) and 0·67 (95% CI; 0·51,0·86; p=0·0018) respectively. Subgroup analysis demonstrated efficacy (reduced continuous LOS, and reduced risk of LOS exceeding either 7 or 12 hours) for prednisolone among patients with more severe exacerbations. The absolute reduction (difference) in the percentage of patients with a LOS exceeding 12 hours (13.7%) represents a number needed to treat of approximately 8 patients to prevent the LOS of 1 patient exceeding 12 hours. Conclusion Oral prednisolone demonstrated a clear benefit over placebo at reducing the LOS in children presenting to a PED with viral associated wheeze; with the greatest efficacy observed among patients with more severe features of wheeze. Aims The use of manipulation under sedation (MUS) of fractures in paediatric emergency departments (PED) has become increasingly popular. Numerous studies show MUS to be safe, effective, and reducing time to manipulation, number of MUAs (manipulation under anaesthetic) and time spent in hospital. Despite this there were many barriers and safety concerns to the introduction of MUS in our hospital. A MUS protocol using 70%Nitrous for upper limb fractures was introduced in December 2016 at our PED. The aim of our study was to evaluate this service regarding safety, cost effectiveness, barriers to its use and to evaluate admissions saved. Methods An audit was conducted of all paediatric eligible forearm and wrist fractures requiring manipulation. Data was collected from two study periods (of 5 months) before and after implementation of protocol for comparisons, FebruaryJuly 2016 and same period in 2017. Data was collected on patient demographics, treatment modality,timings of presentation and treatments,and reasons eligible MUS were not undertaken. Results In 2016, 36 patients who would have been eligible for MUS went on to have admissions and MUA. In 2017 there were 35 eligible patients, 20 who had MUS in the PED and 15 who had admission and MUA. Of the MUS group 100% were successful with no complications or requirement for further surgery and were discharged home within 4 hours. Of the 15 MUA, 11 (73%) the MUS was unable to occur because of staffing issues; presenting out-of-hours or the department being too busy. The average time of presentation of the MUS group was 16:42 and the MUA group 18:08, both out-ofhours for staffing levels. The MUS group waited an average 149 mins between presentation and definitive reduction, compared to 2.2 days in the MUA group.The cost saved per MUS case was average £1300. Conclusion This study demonstrates MUS protocol in a PED is safe and cost efficient, providing a solution to the crises in inpatient beds and busy theatre lists. The biggest barrier to its regular implementation is staff availability out-of-hours. As a result of this study our department are creating a morning 'virtual list' within the ED,increasing MUS capacity within the current service.
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MANIPULATION UNDER 70% NITROUS IN A PAEDIATRIC EMERGENCY DEPARTMENT; THE EFFECTS AND CHALLENGES POST IMPLEMENTATION
Results We identified a total of nine studies that met the inclusion criteria. All studies were retrospective cohort studies deemed to be at low or uncertain risk of bias. Eight studies were conducted in trauma centres in the United States and one in combat support hospitals in Iraq and Afghanistan. Study populations ranged from 84 to 1531 participants. Acute traumatic coagulopathy was present in 31.7% (range 24.6%-40.9%). Mortality was 29.3% (range 21.2%-60%) in those
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